Angelini Pharma and Quiver Bioscience Announce Strategic Research Collaboration and Licensing Agreement to Discover and Advance Novel Therapeutics for Genetic Epilepsies
Business Wire India Angelini Pharma secures exclusive global license rights to future identified drug targets Quiver receives undisclosed advance…